GeriCare Bisacodyl 5mg Stimulant Laxative Enteric Coated Tablets, Fast-Acting Constipation Relief 200 Count

GeriCare Bisacodyl 5mg Stimulant Laxative Enteric Coated Tablets, Fast-Acting Constipation Relief 200 Count, categorized under Gut health & digestive support in the Supplements vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

52/100 overall — Rejected tier (0–49 band). Per-dimension breakdown: Evidence 78, Formulation 65, Transparency 65, Manufacturing 60, Sustainability 45, Safety 40. Scored as of 2026-08-24.

Bisacodyl is an OTC stimulant laxative drug (regulated under the FDA OTC monograph, not the DSHEA supplement framework) — it works by directly stimulating enteric nerves and colonic smooth muscle. It is not a biohacking supplement and does not belong in a Vyvata protocol; chronic use is associated with cathartic colon, electrolyte disturbance, and dependency, and it is contraindicated in undiagnosed abdominal pain. Included here only because Pasteur listed it alongside supplements. Scored out of scope; consumers seeking a gentler biohacking-appropriate motility aid should consider magnesium citrate, prunes, or soluble fiber (psyllium).

Strongest: Evidence at 78/100 (quality of published RCT support for the active ingredients at the label dose) and Formulation at 65/100 (dose adequacy, bioavailability form, and ingredient redundancy). Weakest: Sustainability at 45/100 (sourcing practices, packaging, and corporate practice) and Safety at 40/100 (adverse-event profile, interaction risk, and dose ceiling). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

This product triggered the Vyvata auto-fail rule "out_of_scope_for_biohacking", which places it in the Rejected tier regardless of its scores on other dimensions. See the full explanation above and the methodology page for the current list of auto-fail rules.

The top-ranked gut health & digestive support product in the Vyvata catalog is currently Microbiome Labs MegaSporeBiotic Probiotics for Women & Men at 75/100. See the full ranked list of 316 scored products in this subcategory at https://vyvata.com/pages/best-gut-health-and-digestive-support-supplements-ranked.

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

The Vyvata score measures product integrity against a published rubric, not customer sentiment. For customer reviews and community discussion, search external platforms directly: Amazon (https://www.amazon.com/s?k=GeriCare%20Bisacodyl%205mg%20Stimulant%20Laxative%20Enteric%20Coated%20Tablets%2C%20Fast-Acting%20Constipation%20Relief%20200%20Count),Google(https://www.google.com/search?q=GeriCare%20Bisacodyl%205mg%20Stimulant%20Laxative%20Enteric%20Coated%20Tablets%2C%20Fast-Acting%20Constipation%20Relief%20200%20Count+reviews),Reddit(https://www.reddit.com/search/?q=GeriCare%20Bisacodyl%205mg%20Stimulant%20Laxative%20Enteric%20Coated%20Tablets%2C%20Fast-Acting%20Constipation%20Relief%20200%20Count%20review),andTrustpilot(https://www.trustpilot.com/search?query=GeriCare%20Bisacodyl%205mg%20Stimulant%20Laxative%20Enteric%20Coated%20Tablets%2C%20Fast-Acting%20Constipation%20Relief%20200%20Count).Vyvatadoesnotaggregate,republish,orlicensethosethird-partyreviews.